LC-MS-Based Plasma Metabolomics and Lipidomics Analyses for Differential Diagnosis of Bladder Cancer and Renal Cell Carcinoma

LC-MS-Based Plasma Metabolomics and Lipidomics Analyses for Differential Diagnosis of Bladder Cancer and Renal Cell Carcinoma

Bladder cancer (BC) and Renal cell carcinoma(RCC) are the two most frequent genitourinary cancers in China. In this study, a comprehensive liquid chromatography—mass spectrometry (LC-MS) based method, which utilizes both plasma metabolomics and lipidomics platform, has been carried out to discrimina...

Full description

Bibliographic Details
Main Authors: Xiang Liu, Mingxin Zhang, Xiangming Cheng, Xiaoyan Liu, Haidan Sun, Zhengguang Guo, Jing Li, Xiaoyue Tang, Zhan Wang, Wei Sun, Yushi Zhang, Zhigang Ji
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-05-01
Series:Frontiers in Oncology
Subjects:
bladder cancer
renal cell carcinoma
metabolomics
lipidomics
biomarker
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2020.00717/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2020.00717/full

Similar Items